Valuation: Bould Opportunities PLC

Market Cap 5.71K 5.02K 4.67K 4.28K 8.04K 551K 8.18K 55.42K 21.64K 270K 21.42K 20.96K 935K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -68.89K -64.02K -58.78K -110K -7.56M -112K -760K -297K -3.71M -294K -288K -12.82M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 2021-05-13
Chief Tech/Sci/R&D Officer 61 2025-01-01
Director TitleAgeSince
Director/Board Member 61 2021-05-13
Director/Board Member 61 2025-03-24
Director/Board Member 65 2021-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
+0.97%-1.07%+9.35%+104.71% 9.82B
-1.71%-8.12%+262.11% - 2.44B
-8.82%-11.37%-27.73%-46.75% 1.97B
-1.53%-1.47%-9.14%-18.02% 1.83B
-2.04%-2.24%-27.49%-12.57% 950M
-0.81%-2.93%+23.37%+83.49% 827M
+2.65%+2.65%+47.46%+6.42% 730M
-5.94%-20.16%+22.55%+54.54% 544M
+2.83%+1.60%-13.44%0.00% 538M
Average -1.44%+1.86%+31.89%+21.48% 1.96B
Weighted average by Cap. -0.88%-0.88%+35.23%+57.81%

Financials

2019 2020
Net sales - -
Net income -832K -732K -680K -625K -1.17M -80.34M -1.19M -8.08M -3.16M -39.38M -3.12M -3.06M -136M -306K -269K -250K -230K -431K -29.55M -438K -2.97M -1.16M -14.48M -1.15M -1.12M -50.12M
Net Debt -378K -333K -309K -284K -533K -36.5M -542K -3.67M -1.43M -17.89M -1.42M -1.39M -61.91M -84K -73.91K -68.69K -63.07K -118K -8.11M -120K -816K -319K -3.98M -315K -309K -13.76M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-